Explain this page
Arphra AIPlain-English read on Alignment Healthcare, Inc.’s valuation06-09today
- Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?11d
- Alignment Healthcare Inc (ALHC) Stock Up 7.1% but GF Value Says Overvalued -- GF Score: 84/10012d
- Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?12d
- Alignment Healthcare, Inc. (ALHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript13d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$84.60
+297.36% vs spot
Recommendation
Strong Buy
10 of 11 methods
Method spread
4bull6bear
±5% threshold
Analyst PT consensus: $24.33 (+14.28%)
Candlestick · 1Y
Open in chart workstation →ALHC
21.86-3.49%H 23.33L 13.05MA50 17.79MA200 —Avg vol 4.6M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.61% | +3.96% | +30.21% | +22.78% | +5.45% | +7.80% | +52.40% | +241.73% | -19.60% | +22.99% | +22.99% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$5.62M
3 txns
Net flow
−$5.62M
Aftermarket
LiveLast trade
$21.60
1 sh
Bid
$21.00
1 sh
Ask
$21.82
9,160 sh
Spread
$0.820
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $1.24B | $11.42M | $0.05 |
| Q4 Dec 2025 | $1.01B | -$11.01M | $-0.05 |
| Q3 Sep 2025 | $993.7M | $3.73M | $0.02 |
| Q2 Jun 2025 | $1.02B | $15.67M | $0.07 |
| Q1 Mar 2025 | $926.93M | -$9.11M | $-0.05 |
| Q4 Dec 2024 | $701.24M | -$31.09M | $-0.16 |
Sector & industry today
LiveSectors
- Real Estate+1.26%
- Industrials+1.00%
- Basic Materials+0.65%
- Energy+0.59%
- Healthcare+0.01%
- Utilities-0.07%
- Financial Services-0.24%
- Communication Services-0.55%
- Technology-0.80%
- Consumer Cyclical-0.85%
- Consumer Defensive-1.00%
Top industries (issuer's industry highlighted)
- Medical - Healthcare Plans+1.20%
- Biotechnology+6.56%
- Financial - Mortgages-4.05%
- Electrical Equipment & Parts+3.88%
- Staffing & Employment Services-3.62%
- Software - Services-3.30%
- Software - Infrastructure-3.07%
- Advertising Agencies+2.92%
- Apparel - Footwear & Accessories-2.80%
- Engineering & Construction+2.80%
- Financial - Conglomerates+2.62%
- Luxury Goods+2.47%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?zacks.com·Jun 11, 2026
- Alignment Healthcare Inc (ALHC) Stock Up 7.1% but GF Value Says Overvalued -- GF Score: 84/100gurufocus.com·Jun 10, 2026
- Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?zacks.com·Jun 10, 2026
- Alignment Healthcare, Inc. (ALHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 09, 2026
- Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insidersfool.com·Jun 05, 2026
- Boost Your Portfolio Returns With These 4 Top-Performing Liquid Stockszacks.com·Jun 05, 2026
- Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Yearglobenewswire.com·Jun 03, 2026
- Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Yearglobenewswire.com·Jun 03, 2026
Recent analyst activity
DB- Jun 10, 2026GradeOverweight → OverweightKeyBanc on Alignment Healthcare Inc (ALHC): 'We think the bear points are overblown'KeyBanc
Peers
No peer list available for ALHC.
Total assets
$1.07B
Total debt
$338.07M
Cash & equiv
$577.94M
Operating CF
$139.93M
Free cash flow
$113.15M
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Maroney Dawn Christine officer: President | Sell | 30,000 | $586.43K | Jun 15, 2026 |
KAO JOHN E director, officer: Chief Executive Officer | Sell | 17,107 | $299.97K | May 11, 2026 |
KAO JOHN E director, officer: Chief Executive Officer | Sell | 280,893 | $4.73M | May 11, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $3.95B | $14.75M | -$724K | $-0.00 | -0.02% |
| FY 2024 | $2.7B | -$101.56M | -$128.04M | $-0.67 | -4.74% |
| FY 2023 | $1.82B | -$127.82M | -$148.02M | $-0.79 | -8.12% |
| FY 2022 | $1.43B | -$128.64M | -$149.55M | $-0.83 | -10.43% |
| FY 2021 | $1.17B | -$178.07M | -$195.29M | $-1.14 | -16.72% |